Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Operating income3 4 -$187.4M in 2024+439% since 2022 -$200.0M -$150.0M -$100.0M -$50.0M 0 2022: -$34.8M -$34.8M 2022 2023: -$96.7M -$96.7M 2023 +178% 2024: -$187.4M -$187.4M 2024 +94% Net income3 4 -$167.5M in 2024+309% since 2022 -$200.0M -$150.0M -$100.0M -$50.0M 0 2022: -$41.0M -$41.0M 2022 2023: -$98.1M -$98.1M 2023 +140% 2024: -$167.5M -$167.5M 2024 +71% Operating income5 6 -$52.9M in Q2 FY2025−40% since Q1 FY2025 -$100.0M -$75.0M -$50.0M -$25.0M 0 Q1 FY2025: -$88.4M -$88.4M Q1 FY2025 Q2 FY2025: -$52.9M -$52.9M Q2 FY2025 −40% Net income5 6 -$49.9M in Q2 FY2025−41% since Q1 FY2025 -$100.0M -$75.0M -$50.0M -$25.0M 0 Q1 FY2025: -$84.5M -$84.5M Q1 FY2025 Q2 FY2025: -$84.5M -$84.5M Q2 FY2025 +0% Q2 FY2025: -$49.9M -$49.9M Q2 FY2025 −41% Fiscal year 2021 2022 2023 2024 2025 Research and development $29.4M3 $75.8M4 $143.4M4 Operating income -$34.8M3 -$96.7M4 -$187.4M4 Interest $4.9M3 $1.6M4 $04 Net income -$41.0M3 -$98.1M4 -$167.5M4 Earnings per share -$104.403 -$16.534 -$3.724 Earnings per share (diluted) -$104.403 -$16.534 -$3.724
Total assets3 4 $414.1M in 2024+3942% since 2022 0 $200.0M $400.0M $600.0M 2022: $10.2M $10.2M 2022 2023: $453.0M $453.0M 2023 +4323% 2024: $414.1M $414.1M 2024 −9% Total liabilities3 4 $53.8M in 2024+18% since 2022 0 $20.0M $40.0M $60.0M 2022: $45.5M $45.5M 2022 2023: $47.6M $47.6M 2023 +5% 2024: $53.8M $53.8M 2024 +13% Shareholders’ equity3 4 $360.2M in 2024-$200.0M 0 $200.0M $400.0M $600.0M 2021: -$175.0K -$175.0K 2021 2022: -$35.2M -$35.2M 2022 +20035% 2023: $405.4M $405.4M 2023 2024: $360.2M $360.2M 2024 −11% Cash3 4 $64.4M in 2024+3339% since 2022 0 $200.0M $400.0M $600.0M 2022: $1.9M $1.9M 2022 2023: $405.7M $405.7M 2023 +21574% 2024: $64.4M $64.4M 2024 −84% Total assets5 6 $258.6M in Q2 FY2025−38% since Q1 FY2024 0 $200.0M $400.0M $600.0M Q1 FY2024: $414.1M $414.1M Q1 FY2024 Q2 FY2024: $414.1M $414.1M Q2 FY2024 +0% Q1 FY2025: $362.0M $362.0M Q1 FY2025 −13% Q2 FY2025: $258.6M $258.6M Q2 FY2025 −29% Total liabilities5 6 $20.9M in Q2 FY2025−61% since Q1 FY2024 0 $20.0M $40.0M $60.0M $80.0M Q1 FY2024: $53.8M $53.8M Q1 FY2024 Q2 FY2024: $53.8M $53.8M Q2 FY2024 +0% Q1 FY2025: $79.5M $79.5M Q1 FY2025 +48% Q2 FY2025: $20.9M $20.9M Q2 FY2025 −74% Shareholders’ equity5 6 $237.7M in Q2 FY2025−34% since Q1 FY2024 0 $100.0M $200.0M $300.0M $400.0M Q1 FY2024: $360.2M $360.2M Q1 FY2024 Q2 FY2024: $360.2M $360.2M Q2 FY2024 +0% Q1 FY2025: $282.5M $282.5M Q1 FY2025 −22% Q2 FY2025: $282.5M $282.5M Q2 FY2025 +0% Q2 FY2025: $237.7M $237.7M Q2 FY2025 −16% Cash5 6 $107.7M in Q2 FY2025+67% since Q1 FY2024 0 $50.0M $100.0M $150.0M Q1 FY2024: $64.4M $64.4M Q1 FY2024 Q2 FY2024: $64.4M $64.4M Q2 FY2024 +0% Q1 FY2025: $61.8M $61.8M Q1 FY2025 −4% Q2 FY2025: $107.7M $107.7M Q2 FY2025 +74% Fiscal year 2021 2022 2023 2024 2025 Cash $1.9M3 $405.7M4 $64.4M4 Current assets $3.9M3 $409.5M4 $345.0M4 Total assets $10.2M3 $453.0M4 $414.1M4 Current liabilities $44.1M3 $21.2M4 $25.0M4 Total liabilities $45.5M3 $47.6M4 $53.8M4 Shareholders’ equity -$175.0K3 -$35.2M4 $405.4M4 $360.2M4 Shares outstanding 1.1M shares3 41.2M shares4 46.0M shares4 46.1M shares4
Cash from operations3 4 -$139.7M in 2024+381% since 2022 -$150.0M -$100.0M -$50.0M 0 2022: -$29.1M -$29.1M 2022 2023: -$81.2M -$81.2M 2023 +179% 2024: -$139.7M -$139.7M 2024 +72% Capital spending4 $4.4M in 2024−46% since 2023 0 $2.5M $5.0M $7.5M $10.0M 2023: $8.3M $8.3M 2023 2024: $4.4M $4.4M 2024 −46% Free cash flow4 -$144.2M in 2024+61% since 2023 -$150.0M -$100.0M -$50.0M 0 2023: -$89.4M -$89.4M 2023 2024: -$144.2M -$144.2M 2024 +61% Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2021 2022 2023 2024 2025 Cash from operations -$29.1M3 -$81.2M4 -$139.7M4 Capital spending $8.3M4 $4.4M4 Free cash flow -$89.4M -$144.2M
Compare CARGO Therapeutics, Inc. with another company
Recent filings
Aug 19, 2025 8-K Aug 19, 2025 4 Aug 19, 2025 4 Aug 19, 2025 4 Aug 19, 2025 4 Aug 19, 2025 4 Aug 19, 2025 4 Aug 19, 2025 4 Aug 19, 2025 4 Aug 6, 2025 10-Q Jul 8, 2025 8-K Jul 3, 2025 4 Jul 2, 2025 8-K Jun 23, 2025 4 Jun 20, 2025 8-K Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
